BiomX, Inc. (PHGE)
1.48
-0.36
(-19.57%)
USD |
NYAM |
Apr 20, 11:49
BiomX EPS Diluted (Quarterly) : -8.369 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Johnson & Johnson | 2.141 |
| Nuwellis, Inc. | -1.500 |
| Protagonist Therapeutics, Inc. | -0.6932 |
| ACADIA Pharmaceuticals, Inc. | 1.596 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.34M |
| Total Expenses (Quarterly) | 13.34M |
| Enterprise Value | 17.91M |
| Earnings Yield | -1.61K% |
| Normalized Earnings Yield | -1493.73 |